AAirirFForceorceIInstitute forOOperationalperationalHHealthealth
Col James Swaby
12 February 2004AFPMB – Diagnostics Committee Briefing
AF RAPID: Honduras, CONUS, Iraq, Thailand
2
Ruggedized Advanced Pathogen Identification System (RAPID)
• Polymerase Chain Reaction- PCR• Fluorometric, thermocycler• Easy-to-use software allows the RAPID to automatically collect and interpret data, and then report results• RAPID is 1st tactical, field sustainable, biological detection device in DOD Idaho Technology, Inc.
4
Dengue and Dengue Hemorrhagic Fever
• Dengue virus and its mosquito vectors are distributed worldwide in tropical environments
• Dengue is an increasing problem globally and is now the most important vectorborne viral disease
8
Vectors
• Aedes aegypti is the primary vector of dengue; Aedes albopictus is a secondary vector
• Aedes mosquitoes are day-flying, artificial container breeding species
• Anthrophilic species
9
Military Importance
• Historically, dengue fever is second only to malaria as a source of morbidity & mortality among deployed U.S. military forces
• U.S. military forces remain at significant risk for infection when working in dengue endemic areas
• Public law 105-85
US military advisers in fight against Abu Sayyaf guerrillas-
Philippines
10
Operational Difficulties of Mosquito Surveillance
• Sorting and testing individual mosquitoes can be an impractical and time consuming task
• Medical personnel on deployment may not have entomology background
11
Detection of Dengue Fever Virus & Aedes Mosquito Vectors Using the RAPID
Dengue Virus
• Accurate results in 2 hours, or less
• RAPID allows detection of both virus and vector without sorting
Development of genetic probes for dengue virus and
Aedes vectors allows for
detection of their RNA & DNA,
respectively with PCR technique using RAPID
PCR
RNA
12
The Honduras Problem
DF and DHF are major public health problems in Central America, including Honduras
13
Dengue/Aedes Assays
General technique Reverse transcription-PCR Real-time fluorescence RAPID
Assays were evaluated under
both lab & field conditions
14
Ae. aegypti Assay
An Ae. aegypti specific fluorogenic probe hydrolysis (TAqMan) PCR assay was developed for real-time sampling on the RAPID
15
Dengue Assays
Dengue virus Universal & dengue serotypes 1-4 (DEN 1-4) were developed for screening and serotype identification of infected mosquito & human sera using the RAPID
16
Lab & Field Evaluations
Five basic experiments:I. Evaluation of Aedes aegypti assay specificityII. Evaluation of Aedes aeqypti assay sensitivity in mixed mosquito
poolsIII. Evaluation of dengue virus assay specificity (serotypes I-IV,
Universal) occurring in Aedes aegyptiIV. Evaluation of dengue virus assay sensitivity in mixed mosquito
poolsV. Evaluation of dengue virus assays on human sera
17
Aedes aegypti Assays
• Specificity testing• Extract genomic DNA from 1-2 mosquitoes of different
species.• Performed real time PCR on the RAPID to determine cross
reactivity.• Sensitivity testing
• Extract genomic DNA from pools with up to 30 mosquitoes and one A. aegypti in each pool.
• Performed real time PCR on the RAPID to test assay sensitivity.
18
Dengue Virus Assays
RNA extracted from mosquitoes and tested for Dengue 1, 2, 3, and 4 subtypes. USAMRIID inoculated Aedes aegypti with dengue (1-4), yellow
fever, St. Louis encephalitis, and West Nile viruses (Flaviviridae) Specificity Testing
Individual infected Aedes aegypti tested for cross-reactivity to YF, SLE, WN
Sensitivity Testing Mixed mosquito pools of 10, 25, and 50 with one dengue infected
mosquito inserted in each pool. Human sera were tested in the lab & under field conditions in
Honduras
19
Honduras Field Collections
Breeding sources were abundant
Few personal protective measures were evident--bed nets were rare
20
Honduras Field Collections
Adult and immature mosquitoes were collected from homes in Honduras and from other breeding sources
Mosquitoes were returned to the lab alive for ID and testing
21
Honduras Field Lab
Mosquitoes were identified, sorted & and blind pools were prepared for analysis
22
Aedes aegypti Assay
Lab based testing of Ae. aegypti, Cx. pipiens, Cx. quinqefasciatus, An. stephensi and Oc. taeniorhynchus individual and mixed pools (n-10) showed 100% concordance in sensitivity and specificity
Limit of detection of Ae. aegypti egg pools was 5 individual eggs Field testing in Honduras of panels of individual and mixed pools
(n=30) adult Ae. aegypti and Culex spp. Larvae, pupae and adults showed 100% concordance in sensitivity and 97% for specificity with one false positive
Blind panels (n=16) demonstrated 90% concordance in sensitivity, and 88% specificity
24
Dengue Assay Validation testing was accomplished with a blind panel of 27 dengue
virus-infected and 21 non-dengue Flavivirus-infected mosquitoes (YF, WN, SLE), and 8 dengue viremic and 31 non-dengue febrile patient sera samples
Flavivirus infected mosquitoes showed the DEN universal assay in vitro sensitivity was 100% and specificity was 96%
Each DEN serotype assay in vitro sensitivity was 100%; Den 2 & 4 were 100% specific; DEN 1 & 3 were 98% specific.
25
Dengue Assay
No cross reactivity occurred with other Flavivirus spp.
We were not able to detect Dengue virus in field-collected Ae. aegypti
27
Benefits
Detection of dengue virus and its vectors using the RAPID is a valuable tool for protecting force health and preventing mission crippling disease
Accurate and fast disease and vector assessments for area of operations
Compliance with U.S. public law 105-85
28
USAFA & F.E . Warren AFB assessment Jul 03
• Hantavirus and Plague surveillance• Follow-up plague survey at Colorado
Springs – Aug 03
29
USAFA & F.E . Warren AFB assessed Jul 03
• Samples analyzed for Yersinia pestis and Hantavirus• Samples negative for Y. pestis using RAPID• Confirmation testing performed by CDC
• All samples negative• Hantavirus results
pending
30
Operational Mission to Tallil AB, Iraq Jul 03
• Two person VBDST• Collect specimens, evaluated surveillance/control• Developed Leishmaniasis and sandfly probes • One member returned to conduct field evaluations Oct 03• 1st FY 04 team on-site
31
Thailand Dengue Field Trials Aug 03
• RAPID PCR probe field trials• Dengue universal &
serotype 1,2,3,4 probes• Aedes aegypti probe
• Identified serotype 4 in a wild
Aedes aegypti
32
CANARY Bioagent-Identification Sensor
Bioagent BCell
Pathogen bindsto B-cell
Approach
Tests Against Tularemia
Prototype Sensor
• Detects important pathogens causing: smallpox, tularemia, VEE, plague, brucellosis, cholera, foot-and-mouth
• Very low false positive rate (0.4% over 1288 trials)
• Low-cost: requires only 1 droplet/test
0Time (sec)
10
100
1000
10000
100 200
Sig
nal
(P
ho
ton
s /se
c)
0
600
60
# bacterial particles
Light emitted
Best speed & sensitivity for pathogen-ID test
MIT Lincoln Laboratory
33
Thailand Field Trials Aug 04
• $200K to lyophilize B-cell for CANARY field trials• Comparative field evaluation of:
• CANARY: rugged commercial version• RAPID• Lyophilized B-Cells: Dengue,
Salmonella, Shigella• PCR probes: Dengue,
Salmonella, Shigella• Also conduct JE PCR
probe trials
35
Questions?